These results suggested that adherent and aggregated leukocytes obstruct brain microvessels and are an important cause of no‐reflow after arterial recanalization in ischemic stroke, and TXL could ameliorate leukocyte‐endothelial cell interactions and subsequent no‐reflow in stroke. Here, TXNL1 is linked to stroke disorder.